Fig. 2: The clinical value of IGFBP7 was analyzed in ACRG cohort. | Cell Death Discovery

Fig. 2: The clinical value of IGFBP7 was analyzed in ACRG cohort.

From: Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis

Fig. 2

A The expression difference of IGFBP7 in intestinal and diffuse GC. B The expression difference of IGFBP7 between GC patients with/without perineural invasion. C, D The expression difference of IGFBP7 in GC patients with different pathologic stages or Borrmann stages. E–G The expression level of IGFBP7 in GC tissues with different TNM stages. H The expression difference of IGFBP7 between GC patients with pylorus-sparing radical gastrectomy (STG) operation or total gastrectomy (TG) operation. I, J The overall-survival and disease-free survival analysis of IGFBP7 in GC. K The expression difference of IGFBP7 between GC patients with/without MLH1 expression. L The expression difference of IGFBP7 between GC patients over 55 years old and patients under 55 years old. **P < 0.01.

Back to article page